Can we detect cognitive “super-agers” in Parkinson's disease? Cognitive, neuropsychiatric and motor outcomes in the first 10 years of Parkinson's disease

Abstract

Introduction

Superagers are older individuals who resist age-related cognitive decline and who perform just as well or better than younger people in cognitive tasks. In healthy aging studies, superagers not only experience positive cognitive outcomes (e.g. lower risk of future mild cognitive impairment), but may also experience fewer depressive and anxiety symptoms as they age. We seek to identify superagers in Parkinson's disease (PD) and potential outcomes associated with superager status.

Methods

Data was gathered from the Parkinson's Progression Markers Initiative (PPMI). 689 individuals newly diagnosed with PD were assessed annually for up to 10 years. Participants were classified into three groups: superagers, cognitively normal, and PD mild cognitive impairment (PD-MCI). Multilevel models examined longitudinal group differences in global cognition, depression, anxiety, and motor severity.

Results

A significant main effect of group revealed that superagers performed better than the PD-MCI and cognitively normal groups in global cognition. There were significant group by time interactions, revealing the superagers group was on a more favorable longitudinal trajectory relative to other two groups. Superagers also reported less severe depressive and anxiety symptoms compared to the PD-MCI and the cognitively normal groups. Superagers had a more favorable trajectory of motor symptom severity relative to the cognitively normal and PD-MCI groups.

Conclusion

Superagers with PD may be detected with neuropsychological testing and appear to resist the effects of neurodegeneration in Parkinson's disease. Cognitive studies and trials may benefit from incorporating the concept of superagers, as opposed to a single homogenous cognitively normal group.